What is Invokana?
Invokana (canagliflozing), introduced by Johnson & Johnson in March 2013, has quickly become a very popular drug treatment for type 2 diabetes. Marketing has been very aggressive and has contributed to the drug’s popularity.
Invokana is part of a new class of drugs introduced in the United States called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by inhibiting some kidney functions to increase the amount of sugar excreted in the urine.
This process is supposed to increase glucose production and lower blood glucose levels in diabetic patients. Unfortunately, there are dangerous potential risks users can experience from the side effects.
Van Wey Law is investigating lawsuits for victims throughout the U.S. who have been harmed as a result of the drug maker’s failure to adequately warn the medical community and the public of the risks involved.
Lawsuits to be filed claim that Johnson & Johnson failed to perform the proper studies on the drug before placing it on the market. Financial compensation may be available through an Invokana lawsuit for individuals who have suffered:
- Kidney Failure
- Heart Attack
- Diabetic Ketoacidosis
- Wrongful Death
To review whether you, a friend or family member may be eligible to pursue an Invokana injury claim, request a free consultation and case evaluation. Side effects that have been commonly reported include:
- Kidney Failure
- Kidney Stones
- Kidney Impairment
- Urinary Tract Infections
- Abnormal Weight Loss
- Hypersensitivity Reactions
In early 2015 the FDA issued a drug safety communication about reports of users experiencing diabetic ketoacidosis, which involves high levels of acid accumulating in the blood. Just this past December, the FDA announced that new warnings will be added to the drug label.
The warning on the label will indicate that patients should stop using the drug immediately and seek medical treatment if they begin experiencing signs of ketoacidosis side effects. These can include the following:
- Nausea or Vomiting
- Abdominal Pain
- Confusion, Fatigue, Sleepiness
- Difficulty Breathing
To be eligible for an Invokana lawsuit, you also must have:
- taken Invokana or Farxiga for at least two days
- had type 1 or 2 diabetes for more than 30 days before taking the drugs
- been hospitalized for Diabetic Ketoacidosis while on the either drug (or symptoms within 7 days of the last dose), and had no prior Diabetic Ketoacidosis
If you suffered kidney failure while taking Farxiga or Invokana, you must have:
- Had no underlying kidney problems
- Been diagnosed with kidney failure while on either or the diabetic drugs, or within seven days of the last dose
If you or a loved one were hospitalized due to ketoacidosis or kidney failure, financial compensation may be available. We provide free consultations and claim evaluations to help you determine whether you may be eligible and what your options may be.
Invokana was rushed onto the market and into use despite the many safety concerns of medical experts.
Profit Potential for the Manufacturer
Manufacturers who market diabetes drugs stand to make a large profit because so many Americans have diabetes. Johnson & Johnson is projected to make over 400 billion by the end of 2016, according to market analysts. The CDC statistics show that 11.3 percent of all Americans over the age of 20 have diabetes, while more than one-third of the population has prediabetes.
Invokana was rushed onto the market and into use despite the many safety concerns of medical experts. Janssen (a subsidiary of Johnson & Johnson) is not even sure what the long term adverse effects are or whether the drug’s benefits outweigh its risks. This drug carries a real risk of kidney damage and diabetes patients are already at risk of reduced kidney function as a result of their condition.
If you have experienced adverse side effects while taking Invokana or Farxiga that caused you to be hospitalized, or if a loved one died while taking either of these drugs, you may be able to recover compensation for your medical bills and pain and suffering.